<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d940/6094911/d69fa9d722b1/12881_2018_651_Fig2_HTML.jpg"/> </div> <div class="text-side"> <h1>First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.</h1> <p>PTEN, Phospho-AKT and Phospho-mTOR staining. H&amp;E staining: epithelioid peritoneal mesothelioma (MPM) (a), verrucous (squamous cell) carcinoma (VC) (b), and papillary thyroid carcinoma (c). PTEN: Staining of respective tumors (stromal cells and vascular structures may serve as positive internal control) (d, e, and f). Phospho-AKT: immunostaining of respective tumors (g, h, and i). Phospho-mTOR: strong cytoplasmic staining in the MPM (j), weak cytoplasmic staining in the VC (k), and moderate cytoplasmic staining in the thyroid carcinoma (l); (all magnifications: 200×)</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30111295/" target="_blank">30111295</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>